Vantage Market Research releases its latest comprehensive report on the ‘Tech-Enabled Care Delivery (TECD) Market’ with a forecast period of 2025-2034. In 2023, the global Tech-Enabled Care Delivery (TECD) market size was USD 1.02 Billion, and is calculated at USD 1.203 billion in 2024. The Tech-Enabled Care Delivery (TECD) market is projected to reach USD 6.61 billion in 2034, and register a revenue CAGR of 18.1% over the forecast period (2025-2034).

Market Overview:

The Tech-Enabled Care Delivery (TECD) market is registering robust revenue growth as a result of increasing adoption of telehealth, Mobile Health (mHealth) apps, wearable devices, and remote patient monitoring and elder care solutions gaining steady traction worldwide. These innovations support more efficient healthcare delivery, focusing on convenience and accessibility. Electronic Health Records (EHRs) play a pivotal role by enabling easy access to patient data, streamlining clinical workflows, and fostering better decision-making. Advancements in high-speed Internet and mobile connectivity, emergence of new and more advanced technologies and medical devices, rising adoption of cloud computing, and data analytics have made it possible to create user-friendly patient portals and remote monitoring systems, further enhancing connectivity and real-time access to care. 5G networks and improved data security also facilitate secure transmission of patient information, which is crucial for expanding remote healthcare services. As a result, remote care is becoming more integral in settings such as elder care, chronic disease management, mental health, and primary care.

Government and private sector initiatives supporting healthcare digitization have also been instrumental in driving the shift toward tech-enabled care. This transition has accelerated particularly after the COVID-19 pandemic, which highlighted the need for scalable, accessible healthcare solutions. Increased use of telemedicine and digital health tools has simplified access to care, reducing patient reliance on physical visits to healthcare facilities.

One of the major growth drivers is the rising demand for more convenient and cost-effective healthcare, especially as the global population ages and the prevalence of chronic diseases rises. Remote monitoring technologies, including wearables and telemedicine devices, are crucial in managing long-term conditions like diabetes, hypertension, and heart disease, all of which are becoming more common due to the aging population. Additionally, value-based care models, which focus on preventive care and early intervention, are gaining popularity, encouraging the adoption of tech-enabled solutions. These models aim to improve patient outcomes while reducing healthcare costs, making tech-enabled care increasingly attractive to both providers and patients.

Advancements in Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT) have been contributing to increasing important in tech-enabled care delivery. AI-powered diagnostic tools and predictive analytics are helping healthcare providers make more informed decisions, offering personalized care plans and improving operational efficiency. Furthermore, interoperability between healthcare systems, enabled by EHR integration, ensures smoother data flow across platforms, enhancing coordination between different care providers and leading to better patient outcomes.

Growth of the TECD market is also driven by the rise of virtual care models, such as boutique medicine, virtual-first care, and hospital-at-home services. Boutique medicine, which provides personalized, high-quality care to a limited number of patients, is gaining popularity as more people seek individualized attention. High-intensity care, including services like tele-ICU and remote monitoring, is growing due to its ability to manage patients with severe conditions from the comfort of their homes. This trend is expected to continue, particularly in the context of the hospital-at-home model, which is designed to provide hospital-level care to patients in their own homes, reducing the strain on hospital resources and enhancing patient satisfaction.

The expansion of digital therapeutics (DTx) is another factor contributing to market growth. DTx involves delivering evidence-based therapeutic interventions via digital platforms like apps and wearables, which are used to manage chronic diseases, mental health, and lifestyle changes. Companies like Omada Health are leveraging DTx to help patients manage conditions such as diabetes and obesity. As more DTx products gain regulatory approval and reimbursement support, this segment is expected to grow substantially.

TECD market growth is also driven by rising digital literacy among both patients and healthcare professionals. As more people become comfortable with digital tools, the demand for tech-enabled care services is likely to increase. Also, rising investments in digital health infrastructure, including telehealth platforms, remote monitoring systems, and AI tools, is contributing to market growth.

Looking ahead, the tech-enabled care delivery market is expected to continue expanding as healthcare systems become more scalable, accessible, and affordable. By improving patient care while reducing costs, TECD solutions are helping to address critical challenges in healthcare delivery. As these technologies evolve and integrate into mainstream healthcare systems, they will continue to enhance patient experiences, streamline workflows, and ultimately contribute to better health outcomes across diverse global populations. The ongoing focus on improving healthcare access, reducing inefficiencies, and embracing new technologies will support long-term growth in the Tech-Enabled Care Delivery (TECD) market.

Some Key Takeaways:

• In 2023, North America accounted for largest revenue share, and this trend is expected to continue over the forecast period.
• The US accounted for majority revenue share in North America in 2023, with the presence of major TECD companies playing a crucial role. 
• Europe tech-enabled care delivery market accounted of second-largest revenue share in 2023, with the UK, Germany, and France being major revenue contributors. 
• Asia Pacific tech-enabled care delivery market is emerging as a key growth region, driven by rising traction in countries such as China, Japan, and India. Japan. 
• China, India, and Japan are expected to continue to remain major revenue contributors to the Asia Pacific market over the forecast period. 
• The virtual-first care segment is expected to account for largest revenue share among the care delivery type segments in the global tech-enabled care delivery market over the forecast period.
• The home segment is expected to dominate the application setting segment with largest revenue share over the forecast period.
• The wearable devices & remote monitoring technologies segment is expected to maintain a lead in terms of revenue share among the technology segments over the forecast period.
• Among the end user segments, the healthcare providers segment is expected to account for largest revenue share over the forecast period.
• The competitive landscape in the global Tech-Enabled Care Delivery (TECD) Market  is highly dynamic, marked by presence of both established players and emerging companies.

Company List:

• Teladoc Health
• Omada Health
• Livongo (now part of Teladoc Health)
• Amwell
• MDLive
• BetterHelp
• 98point6
• HealthEdge Software
• TytoCare
• Health Recovery Solutions
• Included Health (formerly Grand Rounds Health)
• Biofourmis
• K Health
• Maven Clinic
• Babylon Health 

Recent Developments:

• October 21, 2024: Health tech companies CopilotIQ and Biofourmis announced a strategic merger that will integrate tech-enabled in-home care solutions, covering a broad range of services from pre-surgical optimization to acute, post-acute, and chronic care management. CopilotIQ specializes in providing remote health monitoring for elderly patients and its platform integrates continuous biomarker tracking, behavioral analytics, and US-licensed nursing visits to improve chronic condition management, focusing primarily on hypertension and diabetes, while Biofourmis delivers both virtual and in-person care-at-home solutions. This merger will bring together CopilotIQ’s direct-to-consumer services with Biofourmis’ enterprise healthcare offerings, creating a comprehensive care model that spans both individual and organizational healthcare needs.
• August 20, 2024: Omada Health announced a partnership with the state of Alaska to improve virtual healthcare access for residents. Through this collaboration, Omada’s virtual behavior change programs — focused on Prevention, Hypertension, and Diabetes — will be integrated into Alaska’s Fresh Start Campaign. The initiative is designed to tackle healthcare access challenges in Alaska’s rural and diverse communities by providing free, comprehensive health programs to residents across the state.
• October 10, 2023: Evernorth Health Services, which is the pharmacy, care, and benefits division of The Cigna Group (NYSE: CI), announced plans to strengthen MDLIVE's virtual care offerings by acquiring the technology and clinical expertise of Bright.md, which is a leader in asynchronous care, triage, and healthcare navigation. Also, MDLIVE will expand its virtual primary care services to incorporate health coaching for patients managing chronic conditions.

Global Tech-Enabled Care Delivery (TECD) Market Segmentation:

By Care Delivery Type:

• Boutique Medicine
• High-Intensity Care
• Virtual-First Care
• Chronic Home Care
• Hospital-at-Home
• Digital Therapeutics
• Others

By Application Setting:

• Home
• Primary Care Clinics
• Post-Acute Care Facilities
• Others

By Technology:

• Wearable Devices & Remote Monitoring Technologies
• Artificial Intelligence (AI) & Machine Learning
• Cloud-Based Health Platforms
• Blockchain & Data Security

By End User:

• Healthcare Providers
• Patients and Consumers
• Payers and Insurers
• Pharmaceutical and Biotech Companies
  • United States

Regional Segmentation: 

North America

• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America 

Middle East & Africa

• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.